Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]
News [14839]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
First-in-human phase 1 study of TAK-931 for solid tumours
Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan
First-in-human phase 1 study of TAK-931 for solid tumours ( Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan )
2 Jun 2018
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance...
Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France
Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients ( Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France )
2 Jun 2018
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for...
Prof William Wierda - MD Anderson Cancer Center, Houston, USA
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients ( Prof William Wierda - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2018
Linking Lynch Syndrome and microsatellite instability in tumours
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
Linking Lynch Syndrome and microsatellite instability in tumours ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Matching personalised therapies to patients in the IMPACT trial
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
Matching personalised therapies to patients in the IMPACT trial ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )
2 Jun 2018
Matching mutations in tumours to precision medicine improves survival
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
Matching mutations in tumours to precision medicine improves survival ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2018
Genomic study links several new cancers to Lynch Syndrome
Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA
Genomic study links several new cancers to Lynch Syndrome ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Taselisib with fulvestrant slows growth of advanced breast cancer
Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
Taselisib with fulvestrant slows growth of advanced breast cancer ( Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA
Atezolizumab with chemotherapy improves PFS in squamous NSCLC ( Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA )
2 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation